share_log

4: Statement of changes in beneficial ownership of securities-Director Finizio Robert G

4: Statement of changes in beneficial ownership of securities-Director Finizio Robert G

4:持股變動聲明-董事 Finizio Robert G
美股SEC公告 ·  2024/07/19 09:36

Moomoo AI 已提取核心訊息

In a recent transaction dated 05/24/2023, Robert G Finizio, associated with ZyVersa Therapeutics, Inc. [ZVSA], was reported to have engaged in a financial action with the company's stock. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting number of shares held by Finizio after the action, were not disclosed in the announcement. The absence of this information leaves a gap in understanding the full impact of the transaction on Finizio's holdings and the company's stock.
In a recent transaction dated 05/24/2023, Robert G Finizio, associated with ZyVersa Therapeutics, Inc. [ZVSA], was reported to have engaged in a financial action with the company's stock. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting number of shares held by Finizio after the action, were not disclosed in the announcement. The absence of this information leaves a gap in understanding the full impact of the transaction on Finizio's holdings and the company's stock.
最近有一筆日期爲05/24/2023的交易,ZyVersa Therapeutics公司[ZVSA]的相關人員Robert G Finizio與該公司的股票進行了財務交易。交易的具體細節,包括所涉及的股票數量、股票的性質、交易價格以及Finizio在此次交易後持有的股票數量等,未在公告中公開。缺乏這些信息使我們難以完全理解此次交易對Finizio持有的股票以及公司的股票造成的影響。
最近有一筆日期爲05/24/2023的交易,ZyVersa Therapeutics公司[ZVSA]的相關人員Robert G Finizio與該公司的股票進行了財務交易。交易的具體細節,包括所涉及的股票數量、股票的性質、交易價格以及Finizio在此次交易後持有的股票數量等,未在公告中公開。缺乏這些信息使我們難以完全理解此次交易對Finizio持有的股票以及公司的股票造成的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息